We're Not Very Worried About Corbus Pharmaceuticals Holdings' (NASDAQ:CRBP) Cash Burn Rate
We can readily understand why investors are attracted to unprofitable companies. Indeed, Corbus Pharmaceuticals Holdings ( NASDAQ:CRBP) stock is up 478% in the last year, providing strong gains for ...
Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors despite daily gains
Shares of Corbus Pharmaceuticals Holdings Inc. CRBP rose 1.40% to $18.78 Friday, on what proved to be an all-around great ...
Corbus Pharmaceuticals Reports Q3 2024 Financials and Updates
Corbus Pharmaceuticals Holdings ( (CRBP) ) has released its Q3 earnings. Here is a breakdown of the information Corbus Pharmaceuticals Holdings ...
Corbus Pharmaceuticals Reports Q3 2024 Financial Results
An update from Corbus Pharmaceuticals ( (CRBP) ) is now available. Corbus Pharmaceuticals, an oncology and obesity-focused company, reported a ...
Corbus Pharmaceuticals Reports 3rd Quarter 2024 Financial Results and Provides a Corporate Update
Completed Enrollment of Dose Escalation Part of Phase 1 Clinical Trial of its Next-Generation Nectin-4 Targeting ADC (CRB-701 ...
Hosted on MSN6d
Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat
Viking Therapeutics' highly anticipated weight-loss pill topped Wall Street's expectations — and a rival pill from Novo ...
manilatimes6d
OTC Markets Group Welcomes Corero Network Security plc to OTCQX
OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading 12,000 U.S. and international securities. Our ...
Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., ...